Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie J Dickmann

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 21, 2012
Quantitative prediction of CYP2B6 induction by estradiol during pregnancy: potential explanation for increased methadone clearance during pregnancyLeslie J Dickmann, Nina Isoherranen
The Oncologist|December 21, 2017
Racial and Ethnic Composition of Cancer Clinical Drug Trials: How Diverse Are We?Leslie J Dickmann, Jennifer L Schutzman
Drug Discovery Today. Technologies|December 17, 2016
Pharmacogenomics in the age of personalized medicineLeslie J Dickmann, Joseph A Ware
Clinical Pharmacology and Therapeutics|April 24, 2019
Can Digital Health Enable Higher Quality Real-World Evidence-Based Decisions?Leslie J Dickmann, Prajakti A Kothare
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 26, 2012
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic propertiesLeslie J Dickmann, Brooke M VandenBrink, Yvonne S Lin
Current Drug Metabolism|April 6, 2012
Effects of interleukin 1β (IL-1β) and IL-1β/interleukin 6 (IL-6) combinations on drug metabolizing enzymes in human hepatocyte cultureLeslie J Dickmann, Sonal K Patel, Larry C Wienkers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 19, 2008
Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screeningLesley A McLaughlin, Leslie J Dickmann, C Roland Wolf, et al.
Molecular Pharmacology|March 27, 2004
Differential roles of Arg97, Asp293, and Arg108 in enzyme stability and substrate specificity of CYP2C9Leslie J Dickmann, Charles W Locuson, Jeffrey P Jones, et al.
Clinical and Translational Science|November 16, 2019
Intrinsic and Extrinsic Pharmacokinetic Variability of Small Molecule Targeted Cancer TherapyEric Reyner, Bert Lum, Jing Jing, et al.
Biochemical Pharmacology|May 8, 2004
Differential activation of CYP2C9 variants by dapsoneMatthew A Hummel, Leslie J Dickmann, Allan E Rettie, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 21, 2012
Quantitative prediction of CYP2B6 induction by estradiol during pregnancy: potential explanation for increased methadone clearance during pregnancyLeslie J Dickmann, Nina Isoherranen
The Oncologist|December 21, 2017
Racial and Ethnic Composition of Cancer Clinical Drug Trials: How Diverse Are We?Leslie J Dickmann, Jennifer L Schutzman
Drug Discovery Today. Technologies|December 17, 2016
Pharmacogenomics in the age of personalized medicineLeslie J Dickmann, Joseph A Ware
Clinical Pharmacology and Therapeutics|April 24, 2019
Can Digital Health Enable Higher Quality Real-World Evidence-Based Decisions?Leslie J Dickmann, Prajakti A Kothare
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 26, 2012
In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic propertiesLeslie J Dickmann, Brooke M VandenBrink, Yvonne S Lin
Current Drug Metabolism|April 6, 2012
Effects of interleukin 1β (IL-1β) and IL-1β/interleukin 6 (IL-6) combinations on drug metabolizing enzymes in human hepatocyte cultureLeslie J Dickmann, Sonal K Patel, Larry C Wienkers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 19, 2008
Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screeningLesley A McLaughlin, Leslie J Dickmann, C Roland Wolf, et al.
Molecular Pharmacology|March 27, 2004
Differential roles of Arg97, Asp293, and Arg108 in enzyme stability and substrate specificity of CYP2C9Leslie J Dickmann, Charles W Locuson, Jeffrey P Jones, et al.
Clinical and Translational Science|November 16, 2019
Intrinsic and Extrinsic Pharmacokinetic Variability of Small Molecule Targeted Cancer TherapyEric Reyner, Bert Lum, Jing Jing, et al.
Biochemical Pharmacology|May 8, 2004
Differential activation of CYP2C9 variants by dapsoneMatthew A Hummel, Leslie J Dickmann, Allan E Rettie, et al.
Pageof 3